Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Cachexia × alkaloid GB18 × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Cancer Cachexia (CC) 1 Cachexia 1

Interventions

Megestrol Acetate 2 ostarine 1 clazakizumab 1 anamorelin 1 alkaloid GB18 1 Sodium Chloride 1 Infliximab 1 Gemcitabine 1 Food 1 Dietary Supplements 1 Caseins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07519564 2026-04-09

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

Kexing Biopharm Co., Ltd.

Phase 1 Not yet recruiting

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡